skip to main content





Back to all Representative Matters
Oct 10, 2018

MediPharm Labs Corp. Completes Qualifying Transaction and Commences Trading on the TSXV

Melanie Cole, Daniel Everall, Amy Marcen-Gaudaur and Brandon Church

On October 1, 2018, MediPharm Labs Corp. (formerly POCML 4 Inc.) (TSXV: LABS) (“MediPharm Labs” or the “Company”) completed its business combination with MediPharm Labs Inc. (the “Target”), which resulted in a reverse take-over of the Company by the shareholders of the Target and constituted the “Qualifying Transaction” of the Company as such term is defined in the policies of the TSX Venture Exchange (the “TSXV”). On October 4, 2018, the shares of MediPharm Labs began trading on the TSXV under the ticker symbol “LABS”.

MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its Australian subsidiary, MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.

Aird & Berlis LLP represented MediPharm with a team comprised of Melanie Cole, Daniel Everall and Amy Marcen-Gaudaur (capital markets) and Brandon Church (corporate services).

Areas of Expertise

Related Representative Matters

Representative Matters
Allied Properties REIT Completes $155 Million Public Equity Offering Margaret T. Nelligan, Sherri M. Altshuler, Anne E. Miatello, Melanie Cole, Liam Tracey-Raymont, Amy Marcen-Gaudaur, Michael D. Smith, Aaron Silver and Barbara Worndl Oct 02, 2018 Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of urban office environments operating in Canada’s major cities, recently completed a $155 million public equity offering of units.
Representative Matters
Medipharm Labs Inc. Completes $22.3 Million Private Placement Melanie Cole, Daniel Everall, Amy Marcen-Gaudaur, Barbara Worndl and Damian Lu Aug 01, 2018 On June 29, 2018, MediPharm Labs Inc. completed a private placement of 2,070,571 units at a price of $10.778 per Unit for aggregate proceeds of approximately $22,316,600 in connection with its proposed business combination with POCML4 Inc.
Representative Matters
Baylin Technologies Inc. Completes $40.25 Million Bought Deal Offering and Acquisition of Alga Microwave Inc. Richard M. Kimel, Sherri M. Altshuler, Sean Mason, Christopher F. Berrigan, Aaron Baer, Amy Marcen-Gaudaur, Aaron T. Collins, Kyle B. Plunkett, Alyssa Gebert, Francesco Gucciardo and Stacey Blydorp Jul 18, 2018 Baylin Technologies Inc., a diversified leading global wireless technology management company, recently completed a $40.25 million bought deal public offering of subscription receipts and 6.5% extendible convertible unsecured debentures and the related acquisition of Alga Microwave Inc.